By Shikha Jain, MD January 23, 2018
Original article Featured in Op-(m)ed, a collection of original articles contributed by Doximity members.
There has been quite a bit of excitement in oncology in the last decade surrounding immunotherapy agents and the amazing results we have seen in a variety of difficult to treat malignancies. These results have included disease processes ranging from lung cancer to lymphomas. We are beginning to see these types of outcomes in the world of GI malignancies, and are finding hope for those with an otherwise poor prognosis.